Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1405969
PUBLISHER: Grand View Research | PRODUCT CODE: 1405969
Hirsutism Market Size, Share & Trends Analysis Report By Treatment Type (Medications, Procedures), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Hirsutism Market Growth & Trends:
The global hirsutism market size is anticipated to reach USD 5.0 billion by 2030 and is anticipated to expand at a CAGR of 7.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market for hirsutism has been negatively affected by the COVID-19 pandemic, which is now widespread. According to the NCBI article in September 2021, a study by Yale et al. examined the connection between hyperandrogenic women, including those with polycystic ovary syndrome (PCOS), hirsutism, and COVID-19.
The study revealed that hospitalization among COVID-19-positive women with hyperandrogenism ranged from 4.5% to 8%, with no significant boost in mortality rates compared to 11.4%-11.7% in those without these conditions. In addition, the incidence of COVID-19 infection or hospitalization in these women did not appear to be significantly associated with their use of therapeutic agents, including spironolactone, estradiol, and metformin.
The demand for laser hair removal is growing, especially in the markets, due to an increasing number of cosmetic procedures and rising consciousness about beauty. Laser hair removal is the most commonly used solution for unwanted hair and its associated cosmetic and psychosomatic concerns as individuals strive for smooth, hairless skin. In 2022, hair removal procedures were a major part of aesthetic treatments, with over 1.8 million operations conducted by women and men, according to the International Society for Aesthetic Plastic Surgery. This increase in hair removal procedures highlights the demand for an effective and permanent solution to unwanted hair.
Hirsutism Market Report Highlights:
- Medications dominated the treatment type segment with more than 56.8% share in 2023, owing to birth control pills the most common medications used to treat hirsutism
- The procedures segment is expected to grow at the fastest CAGR over the forecast period
- The upper lip segment held the largest market share of 25.6% in 2023. The chin segment is anticipated to grow significantly over the forecast period. It is common for women to have light facial hair on the exterior corners of the jawline and upper lip, contributing to the growing prevalence of hirsutism
- North America dominated the market for hirsutism owing to factors such as increasing the prevalence of hirsutism, high purchasing power parity, government support for quality healthcare, and availability of reimbursement
- In October 2022, Sensus healthcare a medical device manufacturer specializing in highly effective, minimally-invasive, non-invasive, and cost-operative treatments for non-oncological conditions and oncological, introduced its movable silk by sensus hair removal system with blended wavelengths
Product Code: GVR-4-68040-166-3
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Treatment type
- 1.2.2. Application
- 1.2.3. End-use
- 1.2.4. Regional scope
- 1.2.5. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.4.5.1. Data for primary interviews in North America
- 1.4.5.2. Data for primary interviews in Europe
- 1.4.5.3. Data for primary interviews in Asia Pacific
- 1.4.5.4. Data for primary interviews in Latin America
- 1.4.5.5. Data for Primary interviews in MEA
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Treatment Type
- 2.2.2. Application
- 2.2.3. End-use
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Hirsutism Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Increasing prevalence of hirsutism among women
- 3.2.1.2. Cosmetic and psychology problems associated with unwanted hair
- 3.2.1.3. Rising prevalence of polycystic ovary syndrome
- 3.2.2. Market restraint analysis
- 3.2.2.1. High cost of the laser hair removal procedures
- 3.2.1. Market driver analysis
- 3.3. Hirsutism Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
- 3.3.1. Industry Analysis - Porter's
Chapter 4. Hirsutism Market: Treatment Type Estimates & Trend Analysis
- 4.1. Treatment type Market Share, 2023 & 2030
- 4.2. Segment Dashboard
- 4.3. Global Hirsutism Market by Treatment Type Outlook
- 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.4.1. Medications
- 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2. Procedures
- 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.3. Others
- 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.1. Medications
Chapter 5. Hirsutism Market: Application Estimates & Trend Analysis
- 5.1. Application Market Share, 2023 & 2030
- 5.2. Segment Dashboard
- 5.3. Global Hirsutism Market by Application Outlook
- 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.4.1. Upper Lip
- 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.2. Chin
- 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.3. Chest
- 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.4. Arms
- 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.5. Others
- 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.1. Upper Lip
Chapter 6. Hirsutism Market: End-use Estimates & Trend Analysis
- 6.1. End-use Market Share, 2023 & 2030
- 6.2. Segment Dashboard
- 6.3. Global Hirsutism Market by End-use Outlook
- 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.4.1. Hospitals
- 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
- 6.4.2. Dermatology Clinics & Aesthetic Centers
- 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.3. Others
- 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.1. Hospitals
Chapter 7. Hirsutism Market: Regional Estimates & Trend Analysis
- 7.1. Regional Market Share Analysis, 2023 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Global Regional Market Snapshot
- 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 7.5. North America
- 7.5.1. U.S.
- 7.5.1.1. Key country dynamics
- 7.5.1.2. Regulatory framework/ reimbursement structure
- 7.5.1.3. Competitive scenario
- 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.2. Canada
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Regulatory framework/ reimbursement structure
- 7.5.2.3. Competitive scenario
- 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.1. U.S.
- 7.6. Europe
- 7.6.1. UK
- 7.6.1.1. Key country dynamics
- 7.6.1.2. Regulatory framework/ reimbursement structure
- 7.6.1.3. Competitive scenario
- 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.2. Germany
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Regulatory framework/ reimbursement structure
- 7.6.2.3. Competitive scenario
- 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.3. France
- 7.6.3.1. Key country dynamics
- 7.6.3.2. Regulatory framework/ reimbursement structure
- 7.6.3.3. Competitive scenario
- 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.4. Italy
- 7.6.4.1. Key country dynamics
- 7.6.4.2. Regulatory framework/ reimbursement structure
- 7.6.4.3. Competitive scenario
- 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.5. Spain
- 7.6.5.1. Key country dynamics
- 7.6.5.2. Regulatory framework/ reimbursement structure
- 7.6.5.3. Competitive scenario
- 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.6. Norway
- 7.6.6.1. Key country dynamics
- 7.6.6.2. Regulatory framework/ reimbursement structure
- 7.6.6.3. Competitive scenario
- 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.7. Sweden
- 7.6.7.1. Key country dynamics
- 7.6.7.2. Regulatory framework/ reimbursement structure
- 7.6.7.3. Competitive scenario
- 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.8. Denmark
- 7.6.8.1. Key country dynamics
- 7.6.8.2. Regulatory framework/ reimbursement structure
- 7.6.8.3. Competitive scenario
- 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.1. UK
- 7.7. Asia Pacific
- 7.7.1. Japan
- 7.7.1.1. Key country dynamics
- 7.7.1.2. Regulatory framework/ reimbursement structure
- 7.7.1.3. Competitive scenario
- 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.2. China
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Regulatory framework/ reimbursement structure
- 7.7.2.3. Competitive scenario
- 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.3. India
- 7.7.3.1. Key country dynamics
- 7.7.3.2. Regulatory framework/ reimbursement structure
- 7.7.3.3. Competitive scenario
- 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.4. Australia
- 7.7.4.1. Key country dynamics
- 7.7.4.2. Regulatory framework/ reimbursement structure
- 7.7.4.3. Competitive scenario
- 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.5. South Korea
- 7.7.5.1. Key country dynamics
- 7.7.5.2. Regulatory framework/ reimbursement structure
- 7.7.5.3. Competitive scenario
- 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.6. Thailand
- 7.7.6.1. Key country dynamics
- 7.7.6.2. Regulatory framework/ reimbursement structure
- 7.7.6.3. Competitive scenario
- 7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.1. Japan
- 7.8. Latin America
- 7.8.1. Brazil
- 7.8.1.1. Key country dynamics
- 7.8.1.2. Regulatory framework/ reimbursement structure
- 7.8.1.3. Competitive scenario
- 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.2. Mexico
- 7.8.2.1. Key country dynamics
- 7.8.2.2. Regulatory framework/ reimbursement structure
- 7.8.2.3. Competitive scenario
- 7.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.3. Argentina
- 7.8.3.1. Key country dynamics
- 7.8.3.2. Regulatory framework/ reimbursement structure
- 7.8.3.3. Competitive scenario
- 7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.1. Brazil
- 7.9. MEA
- 7.9.1. South Africa
- 7.9.1.1. Key country dynamics
- 7.9.1.2. Regulatory framework/ reimbursement structure
- 7.9.1.3. Competitive scenario
- 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.2. Saudi Arabia
- 7.9.2.1. Key country dynamics
- 7.9.2.2. Regulatory framework/ reimbursement structure
- 7.9.2.3. Competitive scenario
- 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.3. UAE
- 7.9.3.1. Key country dynamics
- 7.9.3.2. Regulatory framework/ reimbursement structure
- 7.9.3.3. Competitive scenario
- 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.4. Kuwait
- 7.9.4.1. Key country dynamics
- 7.9.4.2. Regulatory framework/ reimbursement structure
- 7.9.4.3. Competitive scenario
- 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
- 7.9.1. South Africa
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization
- 8.3. Vendor Landscape
- 8.3.1. List of key distributors and channel partners
- 8.3.2. Key customers
- 8.3.3. Key company market share analysis, 2023
- 8.3.4. Ajanta Pharma
- 8.3.4.1. Company overview
- 8.3.4.2. Financial performance
- 8.3.4.3. Product benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. Alma Lasers Ltd.
- 8.3.5.1. Company overview
- 8.3.5.2. Financial performance
- 8.3.5.3. Product benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. Alpaya Dermaceuticals
- 8.3.6.1. Company overview
- 8.3.6.2. Financial performance
- 8.3.6.3. Product benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. Cynosure Inc.
- 8.3.7.1. Company overview
- 8.3.7.2. Financial performance
- 8.3.7.3. Product benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. Lumenis Inc.
- 8.3.8.1. Company overview
- 8.3.8.2. Financial performance
- 8.3.8.3. Product benchmarking
- 8.3.8.4. Strategic initiatives
- 8.3.9. Nisim Inc.
- 8.3.9.1. Company overview
- 8.3.9.2. Financial performance
- 8.3.9.3. Product benchmarking
- 8.3.9.4. Strategic initiatives
- 8.3.10. Sciton International
- 8.3.10.1. Company overview
- 8.3.10.2. Financial performance
- 8.3.10.3. Product benchmarking
- 8.3.10.4. Strategic initiatives
- 8.3.11. Koninklijke Philips N.V
- 8.3.11.1. Company overview
- 8.3.11.2. Financial performance
- 8.3.11.3. Product benchmarking
- 8.3.11.4. Strategic initiatives
- 8.3.12. Merck & Co., Inc.
- 8.3.12.1. Company overview
- 8.3.12.2. Financial performance
- 8.3.12.3. Product benchmarking
- 8.3.12.4. Strategic initiatives
- 8.3.13. Pfizer Inc.
- 8.3.13.1. Company overview
- 8.3.13.2. Financial performance
- 8.3.13.3. Product benchmarking
- 8.3.13.4. Strategic initiatives
- 8.3.14. Cutera Inc.
- 8.3.14.1. Company overview
- 8.3.14.2. Financial performance
- 8.3.14.3. Product benchmarking
- 8.3.14.4. Strategic initiatives
- 8.3.15. El.En. S.p.A.
- 8.3.15.1. Company overview
- 8.3.15.2. Financial performance
- 8.3.15.3. Product benchmarking
- 8.3.15.4. Strategic initiatives
Product Code: GVR-4-68040-166-3
List of Tables
- Table 1 List of abbreviations
- Table 2 List of secondary sources
List of Figures
- Fig. 1 Market research process
- Fig. 2 Data triangulation techniques
- Fig. 3 Primary research pattern
- Fig. 4 Primary interviews in North America
- Fig. 5 Primary interviews in Europe
- Fig. 6 Primary interviews in APAC
- Fig. 7 Primary interviews in Latin America
- Fig. 8 Primary interviews in MEA
- Fig. 9 Market research approaches
- Fig. 10 Value-chain-based sizing & forecasting
- Fig. 11 QFD modeling for market share assessment
- Fig. 12 Market formulation & validation
- Fig. 13 Hirsutism market: market outlook
- Fig. 14 Hirsutism competitive insights
- Fig. 15 Parent market outlook
- Fig. 16 Related/ancillary market outlook
- Fig. 17 Penetration and growth prospect mapping
- Fig. 18 Industry value chain analysis
- Fig. 19 Hirsutism market driver impact
- Fig. 20 Hirsutism market restraint impact
- Fig. 21 Hirsutism market strategic initiatives analysis
- Fig. 22 Hirsutism market: Treatment type movement analysis
- Fig. 23 Hirsutism market: Treatment type outlook and key takeaways
- Fig. 24 Medications market estimates and forecast, 2018 - 2030
- Fig. 25 Procedures market estimates and forecast, 2018 - 2030
- Fig. 26 Others market estimates and forecast, 2018 - 2030
- Fig. 27 Hirsutism Market: Application movement Analysis
- Fig. 28 Hirsutism market: Application outlook and key takeaways
- Fig. 29 Upper Lip market estimates and forecasts, 2018 - 2030
- Fig. 30 Chin market estimates and forecasts,2018 - 2030
- Fig. 31 Chest market estimates and forecasts,2018 - 2030
- Fig. 32 Arms market estimates and forecasts,2018 - 2030
- Fig. 33 Others market estimates and forecasts,2018 - 2030
- Fig. 34 Hirsutism market: End-use movement analysis
- Fig. 35 Hirsutism market: End-use outlook and key takeaways
- Fig. 36 Hospitals market estimates and forecasts, 2018 - 2030
- Fig. 37 Dermatology Clinics & Aesthetic Centers market estimates and forecasts,2018 - 2030
- Fig. 38 Others market estimates and forecasts, 2018 - 2030
- Fig. 39 Global Hirsutism market: Regional movement analysis
- Fig. 40 Global Hirsutism market: Regional outlook and key takeaways
- Fig. 41 Global Hirsutism market share and leading players
- Fig. 42 North America market share and leading players
- Fig. 43 Europe market share and leading players
- Fig. 44 Asia Pacific market share and leading players
- Fig. 45 Latin America market share and leading players
- Fig. 46 Middle East & Africa market share and leading players
- Fig. 47 North America: SWOT
- Fig. 48 Europe SWOT
- Fig. 49 Asia Pacific SWOT
- Fig. 50 Latin America SWOT
- Fig. 51 MEA SWOT
- Fig. 52 North America, by country
- Fig. 53 North America
- Fig. 54 North America market estimates and forecasts, 2018 - 2030
- Fig. 55 U.S.
- Fig. 56 U.S. market estimates and forecasts, 2018 - 2030
- Fig. 57 Canada
- Fig. 58 Canada market estimates and forecasts, 2018 - 2030
- Fig. 59 Europe
- Fig. 60 Europe market estimates and forecasts, 2018 - 2030
- Fig. 61 UK
- Fig. 62 UK market estimates and forecasts, 2018 - 2030
- Fig. 63 Germany
- Fig. 64 Germany market estimates and forecasts, 2018 - 2030
- Fig. 65 France
- Fig. 66 France market estimates and forecasts, 2018 - 2030
- Fig. 67 Italy
- Fig. 68 Italy market estimates and forecasts, 2018 - 2030
- Fig. 69 Spain
- Fig. 70 Spain market estimates and forecasts, 2018 - 2030
- Fig. 71 Denmark
- Fig. 72 Denmark market estimates and forecasts, 2018 - 2030
- Fig. 73 Sweden
- Fig. 74 Sweden market estimates and forecasts, 2018 - 2030
- Fig. 75 Norway
- Fig. 76 Norway market estimates and forecasts, 2018 - 2030
- Fig. 77 Asia Pacific
- Fig. 78 Asia Pacific market estimates and forecasts, 2018 - 2030
- Fig. 79 China
- Fig. 80 China market estimates and forecasts, 2018 - 2030
- Fig. 81 Japan
- Fig. 82 Japan market estimates and forecasts, 2018 - 2030
- Fig. 83 India
- Fig. 84 India market estimates and forecasts, 2018 - 2030
- Fig. 85 Thailand
- Fig. 86 Thailand market estimates and forecasts, 2018 - 2030
- Fig. 87 South Korea
- Fig. 88 South Korea market estimates and forecasts, 2018 - 2030
- Fig. 89 Australia
- Fig. 90 Australia market estimates and forecasts, 2018 - 2030
- Fig. 91 Latin America
- Fig. 92 Latin America market estimates and forecasts, 2018 - 2030
- Fig. 93 Brazil
- Fig. 94 Brazil market estimates and forecasts, 2018 - 2030
- Fig. 95 Mexico
- Fig. 96 Mexico market estimates and forecasts, 2018 - 2030
- Fig. 97 Argentina
- Fig. 98 Argentina market estimates and forecasts, 2018 - 2030
- Fig. 99 Middle East and Africa
- Fig. 100 Middle East and Africa market estimates and forecasts, 2018 - 2030
- Fig. 101 South Africa
- Fig. 102 South Africa market estimates and forecasts, 2018 - 2030
- Fig. 103 Saudi Arabia
- Fig. 104 Saudi Arabia market estimates and forecasts, 2018 - 2030
- Fig. 105 UAE
- Fig. 106 UAE market estimates and forecasts, 2018 - 2030
- Fig. 107 Kuwait
- Fig. 108 Kuwait market estimates and forecasts, 2018 - 2030
- Fig. 109 Market share of key market players- Hirsutism market
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.